ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,837, issued on Oct. 7, was assigned to The Foundry LLC (Menlo Park, Calif.).
"Systems and methods for delivery of a therapeutic agent" was invented by Mark E. Deem (Mountain View, Calif.) and Hanson Gifford (Woodside, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and apparatus are provided for applying an fragment of a neurotoxin such as the active light chain (LC) of the botulinum toxin (BoNT), such as one of the serotype A, B, C, D, E, F or G botulinum toxins, via permeabilization of targeted cell membranes to enable translocation of the botulinum neurotoxin light chain (BoNT-LC) molecule across the targeted cell membrane to the cel...